DMEPOS Mini-Series #4 – Urological Supplies: Intermittent Catheters
If you are a Medicare Part B supplier, then you are aware that billing Medicare B is quite different than billing other payors.
Entries by Jennifer Ottman, CPhT
Metformin ER – Can I Substitute?
Many pharmacies struggle with identifying which metformin ER product they can dispense or substitute, explore the three different strengths …
DMEPOS Mini-Series #3 – Diabetic Test Strips
If you are a Medicare Part B supplier, then you have likely had an audit on diabetic test strips. Billing Medicare Part B is quite different than other payors, and consequently, can be very challenging for pharmacies.
When Should I Obtain a Diagnosis Code for Ozempic?
Since Ozempic® was FDA approved December 5, 2017, PAAS National® has fielded many questions regarding dispensing this expensive injectable diabetic medication.
DMEPOS Mini-Series #2 – Ostomy Supplies
PAAS National® often sees recoupments on ostomy supplies due to unsupported medical records.
Are Your Patients Running Out of Supplies for Their Continuous Glucose Monitor?
Pharmacies often struggle with audits for DMEPOS items. The Medicare Part B/DMEPOS billing model is a complex maze of units, codes and documentation requirements that are very different from billing traditional prescription drugs.
Billing the Correct Insulin for Use in a Pump
Insulin is a very popular audited drug category due to its complexity, frequency of use, and high cost. When used in conjunction with an insulin pump, it adds another layer of complexity.
Self-Audit Series #14: DMEPOS Items
Medicare Part B/DMEPOS billing and documentation rules are VERY different from most of your pharmacy claims – if you don’t have a strong grasp of these differences, or a process for handling the documentation, then you are sure to experience significant problems.
Medicare Not Enforcing Clinical Indications for Certain DMEPOS Categories During the COVID-19 PHE
On March 13, 2020, HHS authorized many waivers and modifications regarding Medicare Part B and DMEPOS claims to help prevent gaps in access to care for patients affected by the PHE.
Self-Audit Series #13: Diabetic Test Strips
Due to the high volume of claims for diabetic test strips, they continue to receive significant attention during third-party audits. Follow the tips below to be prepared if you get an audit.
